TNK BIOTECH ApS: Financial statements 2021
CVR: 30691911
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
TNK BIOTECH ApS (CVR 30691911) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -11,450 and a net result of DKK -14,364 compared with DKK -18,516 the year before. Equity in the 2021 report amounted to DKK -24,558. The company had 1 employee in the financial year.
- Gross Profit
- DKK -11,450
- Profit/Loss
- DKK -14,364
- Equity
- DKK -24,558
- Total Assets
- DKK 32,280
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -11 t. | -14 t. | -25 t. | 1 |
| 2020 | - | -14 t. | -19 t. | -10 t. | 1 |
| 2019 | - | -13 t. | -18 t. | 8 t. | - |
| 2018 | - | 6 t. | 3 t. | 26 t. | - |
| 2017 | - | -10 t. | -14 t. | 23 t. | - |
Official annual report
Find more companies like TNK BIOTECH ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
TNK BIOTECH ApS has published its annual report for 2020. Gross profit came to DKK -14,162, and the net result was DKK -18,516.
About TNK BIOTECH ApS
TNK BIOTECH ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2007. The company is registered under the industry Investering for egen regning. The company was previously named TNK INVEST ApS. The management consists of Thomas Nitschke Kledal. The company is owned by Thomas Nitschke Kledal. The company has 0 employees (2013). In 2025, the company reported a gross profit of DKK -11,363 and a net result of DKK -17,528 compared with DKK -15,724 the year before. Equity in the 2025 report amounted to DKK -82,154.